JTI Korea Expands Sales of Ploom X Advanced Device

JTI by 2FIRSTS.ai

Feb.04.2025

JTI Korea Expands Sales of Ploom X Advanced Device

JTI expands sales of "Ploom X Advanced" heating tobacco device to Coupang and Naver platforms for broader consumer access.

According to a report by N. News on February 3rd, Japan Tobacco International's (JTI) South Korea Company announced that sales of its heated tobacco device, "Ploom X Advanced," will be expanded to include the third-party e-commerce platforms Coupang and Naver.

Since its launch in November 2024, "Ploom X Advanced" has begun selling on the "JTI Korea" page on the Coupang platform and the "Ploom Store" on Naver. Consumers can purchase devices in four colors including Slate Grey, Navy Blue, Black, and Silver through these platforms, with a discount of 40,000 Korean Won (approximately $30).

A spokesperson from JTI Korea stated that the reason for expanding sales channels is to allow "more consumers to experience the modern enjoyment brought by Ploom X Advanced through multiple platforms." They plan to launch a variety of new products such as new cigarette sticks and accessories in February.

References:

[1] JTI코리아, 궐련형 전자담배 신제품 ‘플룸 X 어드밴스드' 판매 채널 확대

Also Read:

[1] JTI debuts new “Ploom X Advanced” in South Korea, full rollout set for November

[2] Japan Tobacco to launch Ploom X Advanced HTP device in South Korea by year-end

[3] New Camel Pod Flavors for Ploom X Advanced Released in Japan

[4] Japanese Tobacco Corporation Launches New Color for Ploom X Advanced

#Asia #Market #South Korea #Heated tobacco products

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Exclusive Interview | What’s Changing in Cigars? A Data Firm’s Perspective on the Industry’s Turning Point

As regulations tighten, consumer habits evolve, and new nicotine products reshape the market, the cigar industry is undergoing a quiet but profound transformation. In this exclusive interview, 2Firsts speaks with Cigar Sense — a data-driven sensory analysis firm — to explore what’s really changing in cigars, and what it means for manufacturers, retailers, and smokers around the world.

Nov.10

Philippine FDA Requires Licenses for Vape Products with Medical Claims

The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.

Dec.22 by 2FIRSTS.ai

UK Guernsey's QuitVape program for youth e-cigarette cessation to end at the end of the month

QuitVape e-cigarette quitting service for teens in Guernsey to end this month, after six-month trial period.

Dec.29 by 2FIRSTS.ai

2Firsts Observation｜VELO at Stockholm Arlanda: Travel-Centric Messaging and Full-Line Flavour Presentation

2Firsts observed at Stockholm Arlanda Airport that British American Tobacco’s VELO positions the airport environment as a core marketing scenario, deploying large-format LED displays, a full flavour matrix, and clear nicotine-strength segmentation. The brand also features an instructional “How to Use VELO” section and multi-pack sales strategy, showcasing its systematic merchandising capabilities in the Nordic travel-retail channel.